Direct acting antiviral treatment for patients with end stage kidney disease with acute hcv infection
Conclusions: sofosbuvir containing regimens were effective and safe for the treatment of acute HCV in patients with ESKD who were on haemodialysis.
Source: Mediterranean Journal of Hematology and Infectious Diseases - Category: Hematology Source Type: research
More News: Dialysis | Hematology | Hemodialysis | Hepatitis | Hepatitis C | Infectious Diseases | International Medicine & Public Health | Study | Urology & Nephrology | Virology